Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...
A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...
Eli Lilly begins denying 340B discounts to hospitals that fail to submit required claims-level data under its reporting rules.
Jean Jethro Alexandre faces federal prison after weaponizing a safety-net drug discount program for personal enrichment.
Amid barbs over the shutdown and broader healthcare funding cuts, a Thursday committee hearing brought bipartisan agreement that more can be done to ensure the pricey drug subsidy program remains a ...
WASHINGTON: The U.S. Department of Health and Human Services building is shown in Washington, DC. (Photo by Mark Wilson/Getty Images) In 1992, Congress created the 340B Drug Pricing Program to provide ...
The acquisition will expand Model N’s capabilities as a leading revenue management platform for life sciences manufacturers and extend its 340B offerings to better serve customers. 340B, a federal ...
Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.
The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a second ...
Participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care. Objectives: To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results